SLC39A6 and neoplasm: This study also indicates that high cytoplasmic and high nuclear SLC39A6 protein expression and high SLC39A6 mRNA expression were associated with classical clinicopathological parameters characteristic of a less aggressive tumours and a better outcome, especially in the ER + subgroup.